Literature DB >> 31786602

Glioblastoma incidence rate trends in Canada and the United States compared with England, 1995-2015.

Faith G Davis1,2, Trenton R Smith1,2, Haley R Gittleman3, Quinn T Ostrom3,4, Carol Kruchko3, Jill S Barnholtz-Sloan3,5.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31786602      PMCID： PMC7032629          DOI： 10.1093/neuonc/noz203

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  5 in total

1.  Brain and central nervous system tumor statistics: access to accurate data for all countries is critical!

Authors:  Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

Review 2.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

3.  The Impact of Hospital Discharge Linkage on Case Ascertainment of Brain Tumors in the Alberta Cancer Registry, 2010-2015.

Authors:  Angela Eckstrand; Lorraine Shack; Truong-Minh Pham; Faith Davis
Journal:  J Registry Manag       Date:  2018

4.  Current Status of Brain Tumor Surveillance in Canada and Why it Matters.

Authors:  Faith Davis; Chenthila Nagamuthu; Jordan Ross; Joseph Megyesi
Journal:  J Registry Manag       Date:  2015

5.  Brain Tumours: Rise in Glioblastoma Multiforme Incidence in England 1995-2015 Suggests an Adverse Environmental or Lifestyle Factor.

Authors:  Alasdair Philips; Denis L Henshaw; Graham Lamburn; Michael J O'Carroll
Journal:  J Environ Public Health       Date:  2018-06-24
  5 in total
  14 in total

Review 1.  Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Authors:  Patrick Y Wen; Michael Weller; Eudocia Quant Lee; Brian M Alexander; Jill S Barnholtz-Sloan; Floris P Barthel; Tracy T Batchelor; Ranjit S Bindra; Susan M Chang; E Antonio Chiocca; Timothy F Cloughesy; John F DeGroot; Evanthia Galanis; Mark R Gilbert; Monika E Hegi; Craig Horbinski; Raymond Y Huang; Andrew B Lassman; Emilie Le Rhun; Michael Lim; Minesh P Mehta; Ingo K Mellinghoff; Giuseppe Minniti; David Nathanson; Michael Platten; Matthias Preusser; Patrick Roth; Marc Sanson; David Schiff; Susan C Short; Martin J B Taphoorn; Joerg-Christian Tonn; Jonathan Tsang; Roel G W Verhaak; Andreas von Deimling; Wolfgang Wick; Gelareh Zadeh; David A Reardon; Kenneth D Aldape; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2020-08-17       Impact factor: 12.300

2.  Allopregnanolone Promotes Migration and Invasion of Human Glioblastoma Cells through the Protein Tyrosine Kinase c-Src Activation.

Authors:  Carmen J Zamora-Sánchez; Claudia Bello-Alvarez; Mauricio Rodríguez-Dorantes; Ignacio Camacho-Arroyo
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

3.  Might changes in diagnostic practice explain increasing incidence of brain and central nervous system tumors? A population-based study in Wales (United Kingdom) and the United States.

Authors:  Michael Tin Chung Poon; Paul M Brennan; Kai Jin; Cathie L M Sudlow; Jonine D Figueroa
Journal:  Neuro Oncol       Date:  2021-06-01       Impact factor: 12.300

Review 4.  Oncolytic Virotherapy in Glioma Tumors.

Authors:  Sergio Rius-Rocabert; Noemí García-Romero; Antonia García; Angel Ayuso-Sacido; Estanislao Nistal-Villan
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

5.  Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.

Authors:  Jieqiong Wen; Wanbin Chen; Yayun Zhu; Pengbo Zhang
Journal:  BMC Cancer       Date:  2021-01-19       Impact factor: 4.430

6.  Recent incidence trend of elderly patients with glioblastoma in the United States, 2000-2017.

Authors:  Boran Chen; Chaoyue Chen; Yang Zhang; Jianguo Xu
Journal:  BMC Cancer       Date:  2021-01-12       Impact factor: 4.430

7.  Kiaa0101 serves as a prognostic marker and promotes invasion by regulating p38/snail1 pathway in glioma.

Authors:  Junhui Liu; Lun Gao; Jianmin Liao; Ji'an Yang; Fan'en Yuan; Qianxue Chen
Journal:  Ann Transl Med       Date:  2021-02

8.  MCT4 Promotes Tumor Malignancy in F98 Glioma Cells.

Authors:  Anna Maria Reuss; Dominik Groos; Ali Ghoochani; Michael Buchfelder; Nicolai Savaskan
Journal:  J Oncol       Date:  2021-04-14       Impact factor: 4.375

Review 9.  Treatment of Older Adult Patients with Glioblastoma: Moving towards the Inclusion of a Comprehensive Geriatric Assessment for Guiding Management.

Authors:  Manik Chahal; Brian Thiessen; Caroline Mariano
Journal:  Curr Oncol       Date:  2022-01-14       Impact factor: 3.677

Review 10.  Exosomal noncoding RNAs: key players in glioblastoma drug resistance.

Authors:  Ahmad Movahedpour; Seyyed Hossein Khatami; Marjan Khorsand; Mahsa Salehi; Amir Savardashtaki; Seyedeh Habibeh Mirmajidi; Babak Negahdari; Nezhat Khanjani; Parisa Naeli; Omid Vakili; Mortaza Taheri-Anganeh
Journal:  Mol Cell Biochem       Date:  2021-07-17       Impact factor: 3.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.